Nevisense
Discover the power of early skin diagnostics
Nevisense is SciBase’s flagship technology for advanced skin diagnostics and research. Combining EIS with AI-powered analysis, Nevisense enables clinicians and researchers to uncover information hidden below the surface of the skin – delivering objective insights that support early detection, accurate assessment, and better outcomes.
How it works: EIS meets AI
How Nevisense Technology Works
- The skin is measured
Nevisense is placed directly against the skin to perform a non-invasive EIS measurement. - A detailed bioelectrical signature is captured
Imperceptible signals capture 700 data points across multiple frequencies and depths. - Cellular properties are revealed
The resulting data reflect changes in tissue structure and cellular organization. - The data are analyzed
Embedded AI algorithms identify patterns and deviations associated with the measured application.
Applications: From cancer detection to skin barrier research
Nevisense is CE-marked and FDA-approved for clinical use in melanoma detection, and also supports the identification of keratinocyte cancers like BCC and SCC. Beyond cancer, it is increasingly used in dermatological research.Applications:
- Melanoma detection: High-sensitivity tool to differentiate between benign and malignant lesions.
- Non-melanoma skin cancer: Supports detection of keratinocyte cancers.
- Skin barrier assessment: Valuable for atopic dermatitis, eczema and other skin conditions.
- Cosmetic testing: Quantify effects of skincare products on the skin barrier.
Built for clinical workflow:
Nevisense is designed for use in everyday clinical settings. The measurement process takes just minutes, requires minimal training, and delivers instant results on screen – helping guide decisions in real time. In research, the data can be exported for deeper analysis, documentation or longitudinal tracking. With a compact form factor, portable probe and easy-to-use interface, Nevisense integrates smoothly into clinical practice and research environments alike.
Clinically and scientifically proven
CE marked (MDR) and FDA-approved device
Proven in the largest clinical study of its kind
Scientifically validated, globally trusted
Nevisense is backed by over three decades of research and a large amount of scientific publications. With 300,000+ patients evaluated worldwide and more than 500 clinics using Nevisense for skin cancer detection, it is a trusted tool for dermatologists, academic researchers and life science companies.
Clinical trials have shown that Nevisense improves diagnostic performance when used alongside traditional examination methods, supporting better outcomes for patients and clinicians.
Get in touch with us
Have questions or want to learn more? Contact SciBase to discover how our solutions can support your work.